PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32060098-0	2020	The DNA cytosine deaminase APOBEC3B is a molecular determinant of platinum responsiveness in clear cell ovarian cancer.	Platinum	66-74	apolipoprotein B mRNA editing enzyme catalytic subunit 3B	Homo sapiens	27-35	
33925044-12	2021	Collectively, APOBEC3B expression was an independent prognostic factor in patients with metastatic urothelial carcinoma treated with platinum-based chemotherapy.	Platinum	133-141	apolipoprotein B mRNA editing enzyme catalytic subunit 3B	Homo sapiens	14-22	
32060098-13	2020	Thus, APOBEC3B is a molecular determinant and a candidate predictive biomarker of the therapeutic response to platinum-based chemotherapy.	Platinum	110-118	apolipoprotein B mRNA editing enzyme catalytic subunit 3B	Homo sapiens	6-14